Barton Russell
- SEC CIK
- 0001867418
In the past year, 3 open-market sale filings worth $30.0K and no purchases.
Current role at each company
- ABOS Acumen Pharmaceuticals, Inc.Chief Operating Officeras of Jan 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $30.0K
- 3 filings
- Net
- −$30.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Barton Russell as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 (view filing) | Jan 21-22 | 2 days | Barton RussellChief Operating Officer | SSale | −2.78K | $1.81 | −$5.04K | −1.3%205.1K after | 2 lots |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Barton RussellChief Operating Officer | SSale | −3.53K | $1.86 | −$6.57K | −2.8%123.3K after | |
| Jan 7, 2026 (view filing) | Jan 5-7 | 2 days | Barton RussellChief Operating Officer | SSale | −9.32K | $1.97 | −$18.4K | −6.8%126.8K after | 3 lots |
| Jan 23, 2025 (view filing) | Jan 21 | 2 days | Barton RussellChief Operating Officer | SSale | −2.91K | $1.61 | −$4.69K | −2.1%136.1K after | 10b5-1 |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Barton RussellChief Operating Officer | SSale | −7.64K | $1.86 | −$14.2K | −7.9%89.2K after | 10b5-1 |
| Jan 19, 2024 (view filing) | Jan 18 | 1 day | Barton RussellChief Operating Officer | SSale | −2.83K | $3.73 | −$10.6K | −2.8%96.9K after | 10b5-1 |